Contact Us

Request a Demo

Condition

B-Cell Non-Hodgkin Lymphomas(NHL)(1)

Chronic Lymphocytic Leukemia (CLL)(1)

Small Lymphocytic Lymphoma (SLL)(1)

Overall Status

Unknown status(1)

Phase

phase 1(1)

Sponsor New

Nanjing Sanhome Pharmaceutical, Co., Ltd.(1)

Intervention New

shc014748m(1)

Study Results

Has Results

Study Documents

Intervention Type

drug(1)

Funder Type

Industry(1)

Study Type

Interventional(1)

Age Group

Any

Youth (0 - 17 years)

Adult (18 - 64 years)

Older Adult (65+ years)

Gender

all(1)

City

B Cell Non Hodgkin Lymphomas(NHL) Clinical Trials

Create an account to Download

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

N

Safety, Tolerability, and Pharmacokinetics of SHC014748M in Patients With Indolent B-Cell Hematologic Malignancies

Unknown status

Chronic Lymphocytic Leukemia (CLL)
+2 more

SHC014748M

Nanjing, Jiangsu, China
+1 more

2019-04-27

Apr 27, 2019

Do More

Create up to 2 groups of studies for comparison and sharing
Get notified when studies are updated
Download tabulated search results instantly
Unlimited searches

Sign UpNot Today

2022 © Clincosm, Inc.

Exploring the universe of clinical trials just got cosmically easier.

Newest Clinical Trials